You May Already Be Sitting on a Goldmine

In the winter of 2004, shortwave operators across America began hearing something strange. Seven seconds after the top of the hour — precisely seven seconds — a burst of digital static tore across the desert bands. A sharp 0.8 seconds of data. 

Then a voice. A furious outlaw with a red mustache and two loaded revolvers shouting, “Varmint! I’m a-gonna b-b-b-blow ya ta smithereenies!” Yep, Yosemite Sam. 

The transmission repeated up the dial — 3700 kHz, 4300, 6500, 10500 — hopping frequencies like a jackrabbit on espresso, perfectly timed, two minutes of pattern, then silence. DXers triangulated the signal to a government RF testing range west of Albuquerque, where drones and directed-energy systems were being evaluated. For weeks, thousands of technically literate listeners heard only static. Until someone realized: the noise wasn’t the message. The noise was protecting it.

Now let me tell you something that should make every CEO in industrial biotechnology sit up straight. Your company is hearing Yosemite Sam every day. And you’re calling him noise.

If Sam were standing in your pilot plant, he’d stomp his boots, empty both pistols into the ceiling, and howl, “Noise?! You data-dodgin’, spreadsheet-squintin’ varmints! I been hollerin’ right on schedule and you’re tellin’ me I ain’t statistically significant?!” 

Comic exaggeration aside, he would have a point. Somewhere in your fermentation logs, your GC traces, your high-throughput screens, there is a 0.8% yield bump. A 1.2% productivity gain. A real, repeatable improvement. And in a mature biofuels or chemicals operation, a 1% yield improvement can be worth tens of millions of dollars per year. That is gold. 

The mine is not hypothetical. It is your existing lab and plant data — fermentation runs, assay results, QC measurements that currently look ambiguous, irreproducible, or dismissed as “just biological noise.” In reality, much of that so-called noise is preventable variation: instrument drift, method inconsistency, workflow variability never engineered to the standard oil and gas or semiconductor industries consider basic hygiene. You are not short on opportunity. You are short on signal clarity.

In the early days of Amyris, Thomas Treynor — the company’s first protein engineer and now CEO of R2DIO (pronounced RADIO) — noticed something alarming. The assays guiding billion-dollar ambitions carried error rates north of 30 percent. Thirty percent is not background variation; it is statistical fog thick enough to lose a wagon train. Later, a fermentation team costing $2–3 million per year ran hypothesis after hypothesis to improve yield and productivity. Smart ideas. Plausible mechanisms. Careful execution.

Each time, the verdict came back: p > 0.05. Not significant. Move on. No one had time for six replicates. Venture clocks tick loudly. Runway is finite. So the team moved on to the next idea. But the biology had not failed. The measurement system had. When analytical variance approaches the magnitude of biological signal, real improvements vanish into static. You abandon gold because it doesn’t glitter enough.

To understand why this happens, it helps to step back to W. Edwards Deming, who transformed manufacturing by forcing leaders to understand variation. Deming distinguished between common cause variation — the routine background hum of a stable system — and special cause variation, the meaningful signal that something has changed. Through Statistical Process Control and Process Behavior Charts, he taught that reacting to noise produces “tampering”: expensive, confidence-eroding mismanagement. Focusing on true signals, by contrast, allows genuine improvement — that’s what R2DIO is up to.  In industrial biotech, we too often invert this logic. We chase noise and ignore signal. We tinker with processes when variation is common cause, and we dismiss real improvements when signal is obscured by preventable measurement slop. If your measurement system cannot reliably distinguish signal from noise, your capital allocation cannot either.

O, we could understand it another way. Picture, for a moment, Yosemite Sam and Bugs Bunny standing in your lab.

Bugs Bunny (nonchalant):  “Eh, looks like biological noise to me, Doc.” 

Yosemite Sam (explodes):  “Noise?! That ain’t biology, you long-eared lagomorph! That’s instrument drift! That’s sloppy methods! That’s workflows built like tumbleweeds instead o’ refineries!”

Beneath the cartoon chaos lies a serious truth: before you declare a signal insignificant, you must be certain your instruments, definitions, and workflows are fit for purpose. Otherwise you are not analyzing biology; you are measuring your own imprecision.

When Amyris tightened its gas chromatography methods and reduced analytical variance, something remarkable occurred. The “biological noise” diminished. Same organisms. Same fermenters. Same scientists. Different clarity. Improvements translated to plant scale. Replicates dropped. Product time-to-market reportedly fell by half. Nothing mystical happened to the microbes. They tuned the dial.

The myth in our sector is that progress comes from more shots on goal — more screens, more strains, more capital. But if your receiver is fuzzy, more experiments amplify confusion. The frontier is not won by firing more bullets. It is won by aiming. Before you raise another round, launch another screening campaign, or abandon another program as “inconclusive,” ask whether your measurement systems are engineered to detect gold. Have you baselined instrument reproducibility? Separated common cause from special cause variation? Tightened methods until they are fit for purpose? Re-interrogated your own historical data with disciplined clarity?

The first gazillionaire in the bioeconomy may not be the one who invents something new. It may be the one who finally hears what was already transmitting — seven seconds past the hour, right on schedule. Yosemite Sam is still yelling. The question is whether you are listening. And we’ve noticed a number of the industry cognoscienti heading to check out R2DIO’s capabilities — for the rest, well, as Yosemite Sam probably did not put it, “What in tarnation? You long-eared galoots, quit squintin’ at static and tune that blasted receiver before I blast ya!”

Category: Top Stories